| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma (NCT05116800) | Brown University | 2022-03-01 |
| Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients (NCT07432932) | Royal Marsden NHS Foundation Trust | 2021-11-19 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas (NCT04906876) | Brown University | 2021-09-01 |
| Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients (NCT05961761) | Niels Junker | 2021-08-17 |
| AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma (NCT04607200) | Agenus Inc. | 2021-02-01 |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (NCT04055220) | Centre Leon Berard | 2020-03-03 |
| Propranolol in Angiosarcoma (NCT04518124) | The Netherlands Cancer Institute | 2019-12-27 |
| Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma (NCT04293289) | Cancer Intelligence Care Systems, Inc. | 2019-11-19 |
| Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer (NCT03860272) | Agenus Inc. | 2019-03-20 |
| Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) (NCT03331250) | Massachusetts General Hospital | 2018-01-18 |
| A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures (NCT02625389) | Guerbet | 2017-11-29 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) (NCT02732678) | Assistance Publique Hopitaux De Marseille | 2016-05-01 |
| Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma (NCT02584309) | Washington University School of Medicine | 2016-02-22 |
| Evaluation of Votrient in Angiosarcoma (NCT02212015) | Heidelberg University | 2014-07-01 |
| Identification, Molecular Epidemiology Angiosarcoma of the Liver France (NCT01786889) | Centre Oscar Lambret | 2013-06-01 |
| Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas (NCT01303497) | Centre Oscar Lambret | 2010-09-10 |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (NCT01042379) | QuantumLeap Healthcare Collaborative | 2010-03-01 |
| Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes (NCT00887809) | Memorial Sloan Kettering Cancer Center | 2009-04-01 |